BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18303828)

  • 1. Synthesis and biological activity of phosphonate analogues and geometric isomers of the highly potent phosphoantigen (E)-1-hydroxy-2-methylbut-2-enyl 4-diphosphate.
    Boëdec A; Sicard H; Dessolin J; Herbette G; Ingoure S; Raymond C; Belmant C; Kraus JL
    J Med Chem; 2008 Mar; 51(6):1747-54. PubMed ID: 18303828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of phosphoantigens: scalable accesses to enantiomers of BrHPP and studies on N-HDMAPP synthesis.
    Brégeon D; Ferron L; Chrétien A; Guillen F; Zgonnik V; Rivaud M; Mazières MR; Coquerel G; Belmant C; Plaquevent JC
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5807-10. PubMed ID: 22902654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiopyrophosphoantigens: solid-phase synthesis and in vitro characterization of a new class of Vgamma9 Vdelta2 T cells activators.
    Breccia P; Angeli F; Cerbara I; Topai A; Auricchio G; Martino A; Colizzi V; Poccia F
    J Med Chem; 2009 Jun; 52(12):3716-22. PubMed ID: 19453173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of chiral phosphoantigens and their activity in gamma delta T cell stimulation.
    Song Y; Zhang Y; Wang H; Raker AM; Sanders JM; Broderick E; Clark A; Morita CT; Oldfield E
    Bioorg Med Chem Lett; 2004 Sep; 14(17):4471-7. PubMed ID: 15357974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of prenyl pyrophosphonates as new potent phosphoantigens inducing selective activation of human Vgamma9Vdelta2 T lymphocytes.
    Zgani I; Menut C; Seman M; Gallois V; Laffont V; Liautard J; Liautard JP; Criton M; Montero JL
    J Med Chem; 2004 Aug; 47(18):4600-12. PubMed ID: 15317470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vγ9Vδ2 T cell activation by strongly agonistic nucleotidic phosphoantigens.
    Moulin M; Alguacil J; Gu S; Mehtougui A; Adams EJ; Peyrottes S; Champagne E
    Cell Mol Life Sci; 2017 Dec; 74(23):4353-4367. PubMed ID: 28669030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A crystallographic investigation of phosphoantigen binding to isopentenyl pyrophosphate/dimethylallyl pyrophosphate isomerase.
    Wouters J; Yin F; Song Y; Zhang Y; Oudjama Y; Stalon V; Droogmans L; Morita CT; Oldfield E
    J Am Chem Soc; 2005 Jan; 127(2):536-7. PubMed ID: 15643873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of analogues of (E)-1-hydroxy-2-methylbut-2-enyl 4-diphosphate, an isoprenoid precursor and human gamma delta T cell activator.
    Van Hoof S; Lacey CJ; Röhrich RC; Wiesner J; Jomaa H; Van Calenbergh S
    J Org Chem; 2008 Feb; 73(4):1365-70. PubMed ID: 18211084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological activity of isopentenyl diphosphate analogues.
    Scholte AA; Eubanks LM; Poulter CD; Vederas JC
    Bioorg Med Chem; 2004 Feb; 12(4):763-70. PubMed ID: 14759736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity and some immunological properties of gammadelta T-cells from patients with gastrointestinal carcinomas.
    Murayama M; Tanaka Y; Yagi J; Uchiyama T; Ogawa K
    Anticancer Res; 2008; 28(5B):2921-31. PubMed ID: 19031935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural studies of Vgamma2Vdelta2 T cell phosphoantigens.
    Zhang Y; Song Y; Yin F; Broderick E; Siegel K; Goddard A; Nieves E; Pasa-Tolic L; Tanaka Y; Wang H; Morita CT; Oldfield E
    Chem Biol; 2006 Sep; 13(9):985-92. PubMed ID: 16984888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replacing the pyrophosphate group of HMB-PP by a diphosphonate function abrogates Its potential to activate human gammadelta T cells but does not lead to competitive antagonism.
    Reichenberg A; Hintz M; Kletschek Y; Kuhl T; Haug C; Engel R; Moll J; Ostrovsky DN; Jomaa H; Eberl M
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1257-60. PubMed ID: 12657258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of pyrophosphate-containing compounds that stimulate Vgamma2Vdelta2 T cells: application to cancer immunotherapy.
    Tanaka Y; Kobayashi H; Terasaki T; Toma H; Aruga A; Uchiyama T; Mizutani K; Mikami B; Morita CT; Minato N
    Med Chem; 2007 Jan; 3(1):85-99. PubMed ID: 17266628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Photo-Crosslinkable Biotin Derivative of the Phosphoantigen (E)-4-Hydroxy-3-Methylbut-2-Enyl Diphosphate (HMBPP) Activates Vγ9Vδ2 T Cells and Binds to the HMBPP Site of BTN3A1.
    Mattarei A; Enzinger M; Gu S; Karunakaran MM; Kimmel B; Berner N; Adams EJ; Herrmann T; Amslinger S
    Chemistry; 2017 Sep; 23(49):11945-11954. PubMed ID: 28631855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-(4-Chlorophenyl)-5,6-dihydro-1,3-oxazepin-7(4H)-one derivatives as lipophilic cyclic analogues of baclofen: design, synthesis, and neuropharmacological evaluation.
    Abdel-Hafez AA; Abdel-Wahab BA
    Bioorg Med Chem; 2008 Sep; 16(17):7983-91. PubMed ID: 18693017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical synthesis and biological activity of bromohydrin pyrophosphate, a potent stimulator of human gamma delta T cells.
    Espinosa E; Belmant C; Pont F; Luciani B; Poupot R; Romagné F; Brailly H; Bonneville M; Fournié JJ
    J Biol Chem; 2001 May; 276(21):18337-44. PubMed ID: 11279081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A regulatory cross-talk between Vgamma9Vdelta2 T lymphocytes and mesenchymal stem cells.
    Martinet L; Fleury-Cappellesso S; Gadelorge M; Dietrich G; Bourin P; Fournié JJ; Poupot R
    Eur J Immunol; 2009 Mar; 39(3):752-62. PubMed ID: 19197941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-guided design of aminopyrimidine amides as potent, selective inhibitors of lymphocyte specific kinase: synthesis, structure-activity relationships, and inhibition of in vivo T cell activation.
    DiMauro EF; Newcomb J; Nunes JJ; Bemis JE; Boucher C; Chai L; Chaffee SC; Deak HL; Epstein LF; Faust T; Gallant P; Gore A; Gu Y; Henkle B; Hsieh F; Huang X; Kim JL; Lee JH; Martin MW; McGowan DC; Metz D; Mohn D; Morgenstern KA; Oliveira-dos-Santos A; Patel VF; Powers D; Rose PE; Schneider S; Tomlinson SA; Tudor YY; Turci SM; Welcher AA; Zhao H; Zhu L; Zhu X
    J Med Chem; 2008 Mar; 51(6):1681-94. PubMed ID: 18321037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoisomeric separation and bioassay of a new organophosphorus compound, O,S-dimethyl-N-(2,2,2-trichloro-1-methoxyethyl)phosphoramidothioate: some implications for chiral switch.
    Zhou S; Wang L; Li L; Liu W
    J Agric Food Chem; 2009 Aug; 57(15):6920-6. PubMed ID: 19603750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, structural studies and biological properties of new TBA analogues containing an acyclic nucleotide.
    Coppola T; Varra M; Oliviero G; Galeone A; D'Isa G; Mayol L; Morelli E; Bucci MR; Vellecco V; Cirino G; Borbone N
    Bioorg Med Chem; 2008 Sep; 16(17):8244-53. PubMed ID: 18752966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.